As previously reported in breast and ovarian cancer [25, 26], the chromosomal region encoding UBR5 is frequently amplified in CRC, and this finding was observed in approximately 50% of the cases in TCGA cohort. The gene discussed is UBR5; the disease is ovarian cancer.